Vnitr Lek 2010, 56(7):774-778

Parvovirus B19 infection - the cause of severe anaemia after renal transplantation

Z. Žilinská1,*, M. Chrastina1, J. Breza1, M. Drakulová2
1 Urologická klinika s Centrom pre transplantácie obličiek Lekárskej fakulty UK a Univerzitnej nemocnice Bratislava, Slovenská republika, prednosta prof. MUDr. Dr. h. c. Ján Breza, DrSc.
2 SYNLAB.SK s.r.o., Bratislava, Slovenská republika, odborný garant MUDr. Monika Drakulová

Anaemia belongs to the most frequent, mutlifactorial complications after kidney transplantation [1,2]. Blood loss during surgery, iron deficiency, inflammation, bone marrow suppression by immunosuppressants and antiviral medication, use of angiotensin-converting enzyme and/or angiotensin receptor blockers, hyperparathyroidism, allograft dysfunction and at last viral infections participate in the development of posttransplant anaemia [1-3]. Persistent aplastic anaemia after kidney transplantation could be caused by parvovirus B19 infection [1,2,4,5].

Keywords: parvovisus B19; anaemia; kidney transplantation; immunoglobulins

Received: May 5, 2010; Published: July 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Žilinská Z, Chrastina M, Breza J, Drakulová M. Parvovirus B19 infection - the cause of severe anaemia after renal transplantation. Vnitr Lek. 2010;56(7):774-778.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Liefeldt L, Buhl M, Schweickert B et al. Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy. Nephrol Dial Transplant 2002; 17: 1840-1842. Go to original source... Go to PubMed...
    2. Winkelmayer WC, Chandraker A. Pottransplantation anemia: management and rationale. Clin J Am Soc Nephrol 2008; 3 (Suppl 2): S49-S55. Go to original source... Go to PubMed...
    3. Waldman M, Kopp JB. Parvovirus B19 and the kidney. Clin J Am Soc Nephrol 2007; 2 (Suppl 1): S47-S56. Go to original source... Go to PubMed...
    4. Arzouk N, Snanoudj R, Beauchamp-Nicoud A et al. Parvovirus B19-induced anemia in renal transplantation: a role for rHuEPO in resistance to classical treatment. Transpl Int 2006; 19: 166-169. Go to original source... Go to PubMed...
    5. Ozeki M, Fukushima T, Ohzeki M et al. A nosocomial parvovirus B19 infection-induced transient aplastic crisis in a patient with chronic renal failure. Clin Nephrol 2006; 65: 141-143. Go to original source... Go to PubMed...
    6. Cossart YE, Field AM, Cant B et al. Parvovirus-like particles in human sera. Lancet 1975; 1: 72-73. Go to original source... Go to PubMed...
    7. Ozawa K, Kurtzman G, Young N. Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro. Blood 1987; 70: 384-391. Go to original source...
    8. Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev 2002; 15: 485-505. Go to original source... Go to PubMed...
    9. Brown KE, Green SW, de Mayolo JA et al. Congenital anaemia after transplacental B19 parvovirus infection. Lancet 1994; 343: 895-896. Go to original source... Go to PubMed...
    10. Finkel TH, Török TJ, Ferguson PJ et al. Chronic parvovirus B19 infection and systemic necrotizing vasculitis: opportunistic infection or aetiological agent? Lancet 1994; 343: 1255-1258. Go to original source... Go to PubMed...
    11. Beckhoff A, Steffen I, Sandoz P et al. Relapsing severe anaemia due to primary parvovirus B19 infection after renal transplantation: a case report and review of the literature. Nephrol Dial Transplant 2007; 22: 3660-3663. Go to original source... Go to PubMed...
    12. Kelly HA, Siebert D, Hammond R et al. The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world. Epidemiol Infect 2000; 124: 449-457. Go to original source... Go to PubMed...
    13. Anderson LJ, Török TJ. Human parvovirus B19. N Engl J Med 1989; 321: 536-638. Go to original source... Go to PubMed...
    14. Martinásková K. Infekčné parvovírusové exantémy detí. Dermatol Prax 2008; 1: 12-14.
    15. Munakata Y, Saito T. Human parvovirus B19 viraemia is associated with neither IgM positivity nor anaemia in patients with rheumatic diseases. Ann Rheum Dis 2006; 65: 272-273. Go to original source... Go to PubMed...
    16. Kühl U, Pauschinger M, Bock T et al. Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 2003; 108: 945-950. Go to original source... Go to PubMed...
    17. Krygier DS, Steinbrecher UP, Petric M et al. Parvovirus B19 induced hepatic failure in an adult requiring liver transplantation. World J Gastroenterol 2009; 15: 4067-4069. Go to original source...
    18. Ľubušký M, Pospíšilová D, Hyjánek J et al. Prenatální infekce plodu parvovirem B19. Čes Gynek 2005; 70: 306-311.
    19. Duranay M, Bali M, Sahin M et al. Parvovirus B19 infection and unresponsiveness to erythropoietin therapy in haemodialysis patients. Nephrol Dial Transplant1998; 13: 779-780. Go to original source... Go to PubMed...
    20. Beske F, Modrow S, Sörensen S et al. Parvovirus B19 pneumonia in a child undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 40: 89-91. Go to original source... Go to PubMed...
    21. Posfay-Barbe KM, Michaels MG. Parvovirus B19 in organ transplant recipients. Curr Opin Organ Transplant 2003; 8: 283-287. Go to original source...
    22. Shan YS, Lee PC, Wang JR et al. Fibrosing cholestatic hepatitis possibly related to persistent parvovirus B19 infection in a renal transplant recipient. Nephrol Dial Transplant 2001; 16: 2420-2422. Go to original source... Go to PubMed...
    23. Lee PC, Hung CJ, Lei HY et al. Parvovirus B19-related acute hepatitis in an immunosuppressed kidney transplant. Nephrol Dial Transplant 2000; 15: 1486-1488. Go to original source... Go to PubMed...
    24. Murer L, Zacchello G, Bianchi D et al. Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation. J Am Soc Nephrol 2000; 11: 1132-1137. Go to original source... Go to PubMed...
    25. Barzon L, Murer L, Pacenti M et al. Investigation of intrarenal viral infections in kidney transplant recipients unveils an association between parvovirus B19 and chronic allograft injury. J Infect Dis 2009; 199: 372-380. Go to original source... Go to PubMed...
    26. Sturm I, Watschinger B, Geissler K et al. Chronic parvovirus B19 infection-associated pure red cell anaemia in a kidney transplant recipient. Nephrol Dial Transplant 1996; 11: 1367-1370. Go to original source...
    27. Waldman M, Kopp JB. Parvovirus-B19-associated complications in renal transplant recipients. Nat Clin Pract Nephrol 2007; 3: 540-550. Go to original source... Go to PubMed...
    28. Cavallo R, Merlino C, Re D et al. B19 virus infection in renal transplant recipients. J Clin Virol 2003; 26: 361-368. Go to original source... Go to PubMed...
    29. Bergallo M, Merlino C, Daniele R et al. Quantitative competitive-PCR assay to measure human parvovirus B19-DNA load in serum samples. Mol Biotechnol 2006; 31: 23-29. Go to original source... Go to PubMed...
    30. Shimmura H, Tanabe K, Ishikawa N et al. Discontinuation of immunosuppressive antimetabolite for parvovirus B19-associated anaemia in kidney transplant patients. Transplant Proc 2000; 32: 1967-1970. Go to original source... Go to PubMed...
    31. Poelsler G, Berting A, Kindermann J et al. A new liquid intravenous immunoglobulin with three dedicated virus reduction steps: virus and prion reduction capacity. Vox Sang 2008; 94: 184-192. Go to original source... Go to PubMed...
    32. Modrof J, Berting A, Tille B et al. Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins. Transfusion 2008; 48: 178-186. Go to original source...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.